Evers; Andreas

Patent Applications and Registrations

Patent applications and USPTO patent grants for Evers; Andreas.The latest application filed is for "selective glucagon receptor agonists comprising a chelating moiety for imaging purposes".

Company Profile

8.35.43

Evers; Andreas - Frankfurt am Main DE
Evers; Andreas - Florsheim DE
Evers; Andreas - Frankfur am Main DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Conjugates comprising an GLP-1/Glucagon dual agonist, a linker and hyaluronic acid Grant 11,141,489 - Kadereit , et al. October 12, 2	2021-10-12
Selective glucagon receptor agonists comprising a chelating moiety for imaging purposes Grant 11,046,743 - Haack , et al. June 29, 2	2021-06-29
Prodrugs comprising an GLP-1/glucagon dual agonist linker hyaluronic acid conjugate Grant 10,806,797 - Kadereit , et al. October 20, 2	2020-10-20
Conjugates comprising an GLP-1/glucagon dual agonist, a linker and hyaluronic acid Grant 10,792,367 - Kadereit , et al. October 6, 2	2020-10-06
Exendin-4 derivatives as dual GLP1/glucagon agonists Grant 10,758,592 - Haack , et al. Sep	2020-09-01
Fgf21 Compound / Glp-1r Agonist Combinations With Optimized Activity Ratio App 20200261542 - GOBEL; Britta ; et al.	2020-08-20
Selective Glucagon Receptor Agonists Comprising A Chelating Moiety For Imaging Purposes App 20200262885 - HAACK; Torsten ; et al.	2020-08-20
Conjugates Comprising An Glp-1/glucagon Dual Agonist, A Linker And Hyaluronic Acid App 20200155688 - KADEREIT; Dieter ; et al.	2020-05-21
FGF21 compound / GLP-1R agonist combinations with optimized activity ratio Grant 10,583,174 - Gobel , et al.	2020-03-10
Compounds as peptidic trigonal GLP1/glucagon/GIP receptor agonists Grant 10,538,567 - Bossart , et al. Ja	2020-01-21
Compounds as peptidic GLP1/glucagon/GIP receptor agonists Grant 10,519,211 - Bossart , et al. Dec	2019-12-31
Functionalized Exendin-4 derivatives Grant 10,253,079 - Haack , et al.	2019-04-09
Prodrugs Comprising An Glp-1/glucagon Dual Agonist Linker Hyaluronic Acid Conjugate App 20180289822 - KADEREIT; Dieter ; et al.	2018-10-11
Fgf21 Compound / Glp-1r Agonist Combinations With Optimized Activity Ratio App 20180236037 - GOBEL; Britta ; et al.	2018-08-23
Exendin-4 Derivatives As Dual Glp1/glucagon Agonists App 20180185450 - Haack; Torsten ; et al.	2018-07-05
Conjugates Comprising An Glp-1/glucagon Dual Agonist, A Linker And Hyaluronic Acid App 20180154005 - KADEREIT; Dieter ; et al.	2018-06-07
Compounds As Peptidic Trigonal Glp1/glucagon/gip Receptor Agonists App 20180155406 - BOSSART; Martin ; et al.	2018-06-07
Compounds As Peptidic Glp1/glucagon/gip Receptor Agonists App 20180155407 - BOSSART; Martin ; et al.	2018-06-07
Exendin-4 derivatives as selective peptidic dual GLP-1/glucagon receptor agonists Grant 9,982,029 - Bossart , et al. May 29, 2	2018-05-29
Exendin-4 derivatives as selective glucagon receptor agonists Grant 9,932,381 - Haack , et al. April 3, 2	2018-04-03
Macrocyclic urea derivatives as inhibitors of TAFIa, their preparation and their use as pharmaceuticals Grant 9,834,527 - Evers , et al. December 5, 2	2017-12-05
Exendin-4 peptide analogues as dual GLP-1/GIP receptor agonists Grant 9,789,165 - Kadereit , et al. October 17, 2	2017-10-17
Exendin-4 derivatives as peptidic dual GLP-1/glucagon receptor agonists Grant 9,775,904 - Bossart , et al. October 3, 2	2017-10-03
Peptidic dual GLP-1/glucagon receptor agonists derived from exendin-4 Grant 9,771,406 - Bossart , et al. September 26, 2	2017-09-26
Dual GLP-1/glucagon receptor agonists derived from exendin-4 Grant 9,758,561 - Bossart , et al. September 12, 2	2017-09-12
Dual GLP-1/GIP receptor agonists Grant 9,751,926 - Kadereit , et al. September 5, 2	2017-09-05
Non-acylated exendin-4 peptide analogues Grant 9,750,788 - Kadereit , et al. September 5, 2	2017-09-05
Dual GLP1/GIP or trigonal GLP1/GIP/glucagon agonists Grant 9,745,360 - Haack , et al. August 29, 2	2017-08-29
Functionalized Exendin-4 Derivatives App 20170216406 - Haack; Torsten ; et al.	2017-08-03
Dual GLP-1/glucagon receptor agonists Grant 9,694,053 - Haack , et al. July 4, 2	2017-07-04
Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa Grant 9,688,645 - Kallus , et al. June 27, 2	2017-06-27
Functionalized exendin-4 derivatives Grant 9,670,261 - Haack , et al. June 6, 2	2017-06-06
Exendin-4 Peptide Analogues As Dual Glp-1/glucagon Receptor Agonists App 20170022260 - Haack; Torsten ; et al.	2017-01-26
Exendin-4 Derivatives as Selective Peptidic Dual GLP-1/Glucagon Receptor Agonists App 20170008944 - BOSSART; Martin ; et al.	2017-01-12
Macrocyclic Urea And Sulfamide Derivatives As Inhibitors Of Tafia App 20160251324 - KALLUS; Christopher ; et al.	2016-09-01
Exendin-4 Derivatives As Dual Glp1/glucagon Agonists App 20160220643 - Haack; Torsten ; et al.	2016-08-04
Exendin-4 Peptide Analogues As Dual Glp-1/glucagon Receptor Agonists App 20160168225 - Haack; Torsten ; et al.	2016-06-16
Exendin-4 derivatives as dual GLP1/glucagon agonists Grant 9,365,632 - Haack , et al. June 14, 2	2016-06-14
Pyridine derivatives and their use in the treatment of conditions associated with pathological thrombus formation Grant 9,346,757 - Nazare , et al. May 24, 2	2016-05-24
Pyrazole derivatives and their use as LPAR5 antagonists Grant 9,346,762 - Nazare , et al. May 24, 2	2016-05-24
Macrocyclic Urea Derivatives as Inhibitors of TAFIa, Their Preparation and Their Use as Pharmaceuticals App 20160137618 - Evers; Andreas ; et al.	2016-05-19
Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa Grant 9,309,207 - Kallus , et al. April 12, 2	2016-04-12
Macrocyclic Urea And Sulfamide Derivatives As Inhibitors Of Tafia App 20160024033 - KALLUS; Christopher ; et al.	2016-01-28
Benzo[1,3]dioxine derivatives and their use as LPAR5 antagonists Grant 9,221,784 - Nazare , et al. December 29, 2	2015-12-29
Exendin-4 Derivatives as Selective Glucagon Receptor Agonists App 20150368311 - HAACK; Torsten ; et al.	2015-12-24
Peptidic Dual Glp-1/glucagon Receptor Agonists Derived From Exendin-4 App 20150322129 - Bossart; Martin ; et al.	2015-11-12
Dual Glp-1/glucagon Receptor Agonists Derived From Exendin-4 App 20150322128 - Bossart; Martin ; et al.	2015-11-12
Exendin-4 peptide analogues Grant 9,181,305 - Haack , et al. November 10, 2	2015-11-10
Exendin-4 Derivatives As Peptidic Dual Glp-1/glucagon Receptor Agonists App 20150315260 - Bossart; Martin ; et al.	2015-11-05
Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa Grant 9,126,955 - Kallus , et al. September 8, 2	2015-09-08
Dual GLP-1/Glucagon Receptor Agonists App 20150164997 - Haack; Torsten ; et al.	2015-06-18
Exendin-4 Peptide Analogues as Dual GLP-1/GIP Agonists App 20150164995 - Kadereit; Dieter ; et al.	2015-06-18
Exendin-4 Peptide Analogues App 20150166625 - Haack; Torsten ; et al.	2015-06-18
Non-acylated Exendin-4 Peptide Analogues App 20150164996 - Kadereit; Dieter ; et al.	2015-06-18
Dual GLP-1/GIP Receptor Agonists App 20150166627 - Kadereit; Dieter ; et al.	2015-06-18
Pyrazole Derivatives And Their Use As LPAR5 Antagonists App 20150141477 - Nazare; Marc ; et al.	2015-05-21
Pyridine Derivatives And Their Use In The Treatment Of Conditions Associated With Pathological Thrombus Formation App 20150141471 - Nazare; Marc ; et al.	2015-05-21
Benzo[1,3]Dioxine Derivatives And Their Use As LPAR5 Antagonists App 20150111889 - Nazare; Marc ; et al.	2015-04-23
Dual Glp1/gip Or Trigonal Glp1/gip/glucagon Agonists App 20140221281 - HAACK; Torsten ; et al.	2014-08-07
Exendin-4 Derivatives as dual GLP1/GIP or trigonal GLP1/GIP/Glucagon Agonists App 20140213513 - Haack; Torsten ; et al.	2014-07-31
Macrocyclic Urea And Sulfamide Derivatives As Inhibitors Of Tafia App 20140206760 - Kallus; Christopher ; et al.	2014-07-24
Functionalized Exendin-4 Derivatives App 20140206609 - Haack; Torsten ; et al.	2014-07-24
Exendin-4 Derivatives App 20140206608 - Haack; Torsten ; et al.	2014-07-24
Macrocyclic urea and sulfamide derivatives as inhibitors of tafia Grant 8,722,655 - Kallus , et al. May 13, 2	2014-05-13
Exendin-4 Derivatives As Dual Glp1/glucagon Agonists App 20140100156 - HAACK; Torsten ; et al.	2014-04-10
Macrocyclic Urea And Sulfamide Derivatives As Inhibitors Of Tafia App 20140039011 - Kallus; Christopher ; et al.	2014-02-06
Exedin-4 Peptide Analogues App 20130336893 - HAACK; Torsten ; et al.	2013-12-19
Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa Grant 8,580,777 - Kallus , et al. November 12, 2	2013-11-12
Urea and sulfamide derivatives as inhibitors of TAFIa Grant 8,389,764 - Kallus , et al. March 5, 2	2013-03-05
MACROCYCLIC UREA AND SULFAMIDE DERIVATIVES AS INHIBITORS OF TAFIa App 20110178130 - Kallus; Christopher ; et al.	2011-07-21
UREA AND SULFAMIDE DERIVATIVES AS INHIBITORS OF TAFIa App 20100035930 - KALLUS; Christopher ; et al.	2010-02-11